Clinical Trials & Results

Search or filter the listing below to find a trial or results of a completed trial.

View Actively Recruiting Clinical Trials

Click here to see trials currently recruiting participants

Filter

Health Condition

Toggle

Study Status

Toggle

Age group

Toggle

Gender

Toggle

Phase

Toggle

Study Types

Toggle

Showing 20 of 33 Results

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

Clear Filters

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

respiratory-icon.png
Condition(s):
Chronic Obstructive Pulmonary Disease
Status:
Terminated
Requirements:
20 Years to 75 Years
Interventions:
Drug: TV48108 | Drug: Placebo
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

inflammation-icon.png
Condition(s):
Stable Renal Transplant Recipients
Status:
Terminated
Requirements:
18 Years and older
Interventions:
Drug: mycophenolate mofetil (Myfenax) | Drug: mycophenolate mofetil (Cellcept)
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Comparing the Efficacy and Safety of Fremanezumab for Chronic Cluster Headache

headache-icon.png
Condition(s):
Chronic Cluster Headache
Status:
Terminated
Requirements:
18 Years to 70 Years
Interventions:
Drug: Fremanezumab | Drug: Placebo
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Disease Progression Study for the Treatment of RRMS

brain-icon.png
Condition(s):
Relapsing Remitting Multiple Sclerosis
Status:
Terminated
Requirements:
18 Years to 50 Years
Interventions:
Drug: Glatiramer Acetate | Drug: Betaseron | Drug: Rebif
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children

muscle-icon.png
Condition(s):
Growth Hormone-Deficiency
Status:
Terminated
Requirements:
3 Years to 11 Years
Interventions:
Drug: TV-1106 | Drug: somatropin
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Effect of a 5-Day Regimen on Peripheral Stem Cell Mobilization

disease-icon.png
Condition(s):
Healthy Participants
Status:
Terminated
Requirements:
18 Years to 60 Years
Interventions:
Drug: Tbo-filgrastim
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Efficacy and Safety of Fremanezumab for Episodic Cluster Headache

headache-icon.png
Condition(s):
Episodic Cluster Headache
Status:
Terminated
Requirements:
18 Years to 70 Years
Interventions:
Drug: Fremanezumab | Drug: Placebo
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Efficacy of QVAR vs. Flovent Diskus in Participants with Poorly Controlled Asthma

respiratory-icon.png
Condition(s):
Asthma
Status:
Terminated
Requirements:
12 Years to 70 Years
Interventions:
Drug: Qvar | Drug: Flovent Diskus
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Efficacy, Safety and Tolerability Study of Glatiramer Acetate in Subjects With Multiple Sclerosis

brain-icon.png
Condition(s):
Relapsing-Remitting Multiple Sclerosis
Status:
Terminated
Requirements:
18 Years to 55 Years
Interventions:
Drug: Glatiramer Acetate | Drug: Placebo
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Evaluate the Safety and Efficacy of Reslizumab for Patients With Eosinophilic Asthma

respiratory-icon.png
Condition(s):
Eosinophilic Asthma
Status:
Terminated
Requirements:
12 Years to 75 Years
Interventions:
Drug: Reslizumab
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Evaluation of Safety and Tolerability of Long-term TEV-50717 for Treatment of Tourette Syndrome

brain-icon.png
Condition(s):
Tourette Syndrome
Status:
Terminated
Requirements:
6 Years to 17 Years
Interventions:
Drug: TEV-50717 | Drug: Placebo
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Exploring the Long Term Safety, Tolerability and Clinical Effect of Laquinimod

brain-icon.png
Condition(s):
Relapsing Remitting Multiple Sclerosis
Status:
Terminated
Requirements:
18 Years to 50 Years
Interventions:
Drug: Laquinimod | Drug: Placebo
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Extension Study of Talampanel for Amyotrophic Lateral Sclerosis

brain-icon.png
Condition(s):
Amyotrophic Lateral Sclerosis
Status:
Terminated
Requirements:
18 Years to 80 Years
Interventions:
Drug: Talampanel
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Healthy and COPD Participants to Evaluate the Efficacy and Safety of Inhaled TV46017

respiratory-icon.png
Condition(s):
Chronic Obstructive Pulmonary Disease (COPD)
Status:
Terminated
Requirements:
20 Years to 75 Years
Interventions:
Drug: TV46017 | Drug: Placebo
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Long-Term Safety and Efficacy of Fremanezumab for the Prevention of Cluster Headache

headache-icon.png
Condition(s):
Cluster Headache
Status:
Terminated
Requirements:
18 Years to 70 Years
Interventions:
Drug: Fremanezumab
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Nuvigil and Provigil Pregnancy Registry

disease-icon.png
Condition(s):
Narcolepsy | Obstructive Sleep Apnea | Shift Work Sleep Disorder
Status:
Terminated
Requirements:
Child, Adult, Older Adult
Interventions:
Drug: Modafinil/armodafinil
Learn more The primary objective of the Nuvigil/Provigil Pregnancy Registry is to characterize the pregnancy and fetal outcomes associated with Nuvigil and Provigil exposure during

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

cancer-icon.png
Condition(s):
Glioblastoma Multiforme|Anaplastic: Astrocytoma,Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma
Status:
Terminated
Requirements:
18 Years and older
Interventions:
Drug: Talampanel
Learn more Please refer to ClinicalTrials.gov for a description of the trial

PK, Safety,and Efficacy of Omacetaxine in Patients With Chronic Myeloid Leukemia

cancer-icon.png
Condition(s):
Chronic Myeloid Leukemia
Status:
Terminated
Requirements:
18 Years and older
Interventions:
Drug: Omacetaxine mepesuccinate
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Safety, Tolerability and Effect of Laquinimod in Subjects With Relapsing Multiple Sclerosis

brain-icon.png
Condition(s):
Relapsing Multiple Sclerosis
Status:
Terminated
Requirements:
Child, Adult, Older Adult
Interventions:
Drug: Laquinimod
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate

brain-icon.png
Condition(s):
Relapsing Remitting Multiple Sclerosis
Status:
Terminated
Requirements:
18 Years to 55 Years
Interventions:
Drug: Glatiramer Acetate | Drug: Placebo | Drug: Prednisone
Learn more Please refer to ClinicalTrials.gov for a description of the trial